Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Medical News
  3. Dermatology

Review Examines Potential of AI Tools for Physician Burnout

01/10/2025
News Faviconpracticaldermatology.com

Patient documentation tools powered by AI have the potential to alleviate burnout among dermatologists by streamlining administrative tasks, according to a recent review published in the Journal of Drugs in Dermatology.

"The prevalence of burnout among United States (US) dermatologists has surged, reaching 49% in 2023, with a growing volume of bureaucratic tasks (eg, charting, paperwork) the leading factor behind professional fatigue," the authors wrote. "We [sought] to explore the competitive landscape and efficacy of AI-powered patient documentation to alleviate burnout among dermatologists by optimizing documentation practices while maintaining accuracy."

The review included 18 automated documentation products currently available in the healthcare market. Tools reviewed in the analysis were designed to integrate with electronic health record (EHR) systems with the goal of reducing charting and paperwork burden while maintaining HIPAA compliance and accessibility. Some of the key features evaluated included language support, mobile compatibility, and usability for individual and institutional users. Based on the analysis results, the authors expressed confidence these tools could significantly improve clinician workflows, decrease burnout risk, and allow dermatologists to dedicate more time to patient care during visits. 

"A thorough evaluation of these products in clinical settings is needed to assess their efficacy," they wrote. "Longitudinal studies should be conducted to determine their impact on physician well-being. Collaboration between stakeholders, including healthcare workers, researchers, developers, and regulatory agencies, is needed to establish guidelines for the integration and use of these products."

Source: Roth J, et al. Journal of Drugs in Dermatology. 2025. Doi:10.36849/JDD.8583

Schedule15 Jan 2025